Breaking News
Sort by:
Top Post
Novalis Biotech Invests in Ultra Sensitive Genomics Technology by Rarity Bioscience
Rarity Bioscience announces a new strategic investment from Belgium-based Novalis Biotech. The investment is facilitated […]
Nanoform Receives Funding to Solve Challenges for Global Health
Nanoform, an innovative nanoparticle medicine enabling company, announces that Proof of Concept studies will be […]
Vensana Capital Raises $325 Million and Expands Team to Back Transformative Medical Technology Innovations
Vensana Capital today announced the closing of its second fund, Vensana Capital II, with $325 million […]
Envisagenics Raises Series A Financing to Scale its AI-powered RNA Splicing Drug Discovery Platform
Envisagenics, an Artificial Intelligence-driven biotechnology company focused on the discovery and development of novel RNA […]
New Startup Aglaia Therapeutics Raises €4m in Seed Funding to Overcome Resistance in Oncology Targeted Therapies
Aglaia Therapeutics, a biotechnology startup developing promising new therapies that can overcome resistance to current targeted therapies […]
Diamyd Medical and Partners are Awarded SEK 40 Million in VINNOVA Funding for the Prevention of Autoimmune Diseases
The Swedish governmental innovation agency VINNOVA provides SEK 40 million in financing for an innovation milieu in […]
AstraZeneca to Invest $360m in Advanced Manufacturing Facility in Ireland
AstraZeneca is planning on establishing a next-generation active pharmaceutical ingredient (API) manufacturing facility for small […]
Elevian Raises $40 Million Series A to Advance Treatments for Stroke Recovery and Age-Related Diseases
Elevian, an emerging biotech company developing medicines that restore youthful regenerative capacity with the potential […]
Beyond Ventures' First Investment, Prenetics, Becomes First Hong Kong Unicorn to Go Public
Hong Kong-based venture capital firm Beyond Ventures is pleased to support today’s announcement by the […]
Innova Medical Group Gifts £10m to Launch Global Pandemic Institute in Liverpool
Innova Medical Group, a global health innovator and the world’s largest provider of rapid antigen […]
Provepharm Life Solutions Raises €120 Million
Provepharm Life Solutions, a private French pharmaceutical company that finds new applications for well-known molecules, […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more